Thus, in T-ALL we just see aberrant expression of splenic NKL homeobox genes without PBX1 activity while in HL we find aberrant expression of PBX1 without activation of splenic NKL homeobox genes. The gene discussed is PBX1; the disease is Hodgkins lymphoma.